Scarica l'app Stockscreener
24.26
5.97%
-1.54
Dopo l'orario di chiusura:
24.74
0.48
+1.98%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Staar Surgical Co Borsa (STAA) Ultime notizie
ISS recommendation may toll the bell for STAAR–Alcon deal, validates Broadwood - Investing.com
STAAR Surgical (STAA): A Fresh Look at Valuation After Recent Share Price Pullback - simplywall.st
STAAR Surgical (STAA) Urges Stockholders to Support Alcon Merger - GuruFocus
STAAR disputes Broadwood’s claims about acquisition offers - Investing.com India
STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon - Stock Titan
Independent Poxy Advisory Firms Issues Recommendations to Shareholders of Broadwood Partners - MarketScreener
Staar sale to Alcon eclipsed by shareholder, proxy advisor concerns - BioWorld MedTech
Broadwood Partners All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote AGAINST Sale to Alcon - MarketScreener
ISS recommends Staar shareholders reject Alcon's $1.5 billion offer - Reuters
Alcon's (ALC) Proposed Acquisition Faces Major Opposition - GuruFocus
ISS Recommends Staar Shareholders Vote Against Alcon Merger - Orange County Business Journal
Broadwood: Proxy advisory firms recommend Staar shareholders vote against sale - TipRanks
Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon - MarketScreener
Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon - Yahoo Finance
STAAR Surgical (STAA) Shareholders Advised to Reject Alcon's Acq - GuruFocus
Broadwood urges “AGAINST” vote on Alcon deal as advisors dissent - Stock Titan
Broadwood Partners Comments on STAAR Surgical’s Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon - Stock Titan
STAAR Surgical Announces Merger with Alcon Amid Legal Challenges - TradingView
Where Does STAAR Surgical Stand After EVO+ Launch and Recent Share Price Swings? - Yahoo
Large Staar Holders Oppose $1.5B Sale - Orange County Business Journal
Broadwood slams STAAR board over “carelessness” in Alcon sale defense By Investing.com - Investing.com Canada
Broadwood slams STAAR board over “carelessness” in Alcon sale defense - Investing.com
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates STAA, GES, SMLR on Behalf of Shareholders - GlobeNewswire Inc.
STAAR Surgical holders should vote against sale to Alcon, Glass Lewis says - MSN
Investor Group Opposes Alcon's Acquisition of STAAR Surgical (AL - GuruFocus
Broadwood issues letter to Staar Surgical board questioning ‘rush’ in Alcon sale - TipRanks
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale - MarketScreener
Will STAAR Surgical Company benefit from macro trendsWeekly Trend Summary & Stock Portfolio Risk Management - newser.com
Global Myopia Treatment Devices Market Poised for Strong Growth at a CAGR of ~8% by 2032, Driven by Technological Innovations and Increasing Eye Care Demand | DelveInsight - GlobeNewswire
Glass Lewis recommends against STAAR–Alcon merger, bolstering Broadwood’s campaign - Investing.com
Live market analysis of STAAR Surgical CompanyMarket Movers & Real-Time Chart Breakout Alerts - newser.com
STAAR Surgical (STAA): A Fresh Look at Valuation Following Recent Share Price Cooldown - simplywall.st
Glass Lewis Issues Recommendations to Shareholders of STAAR Surgical Company - MarketScreener
STAAR Surgical Board Defends $1.5 Billion Alcon Acquisition Plan - Finimize
AI Insurance Is Expensive - Bloomberg.com
Alcon (ALC) Faces Opposition in Staar Surgical Merger Deal - GuruFocus
STAAR urges shareholders to approve Alcon merger despite Glass Lewis report - Investing.com India
STAAR Surgical (STAA): Proxy Adviser Urges Rejection of Alcon De - GuruFocus
Glass Lewis Advises Against Alcon (ALC) Acquisition of STAAR - GuruFocus
STAAR Surgical Provides Information to Shareholders - MarketScreener
Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon - MarketScreener
Broadwood Partners Questions Integrity of STAAR Surgical’s Last-Minute Forecast Change and Fairness Opinion in Sale to Alcon - Stock Titan
Defender Capital Opposes STAAR Surgical's Proposed Acquisition By Alcon - Nasdaq
STAAR Surgical Faces Shareholder Clash Over Alcon Buyout - Finimize
Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon - Yahoo Finance
STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company - Stocktwits
STAAR shareholders urged to vote for Alcon merger with 59% premium - Investing.com Canada
Yunqi Capital opposes sale of STAAR Surgical to Alcon - Investing.com
Yunqi Capital opposes sale of STAAR Surgical to Alcon By Investing.com - Investing.com Nigeria
Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon - The Joplin Globe
$62/Share Offer Challenged: STAAR Shareholder Yunqi (5.1%) Reiterates Opposition Ahead of Vote - Stock Titan
Broadwood urges STAAR shareholders to reject $28 per share Alcon deal - Investing.com
Broadwood urges shareholders to vote against proposed acquisition of STAAR by Alcon - MarketScreener
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Judgment in Proposed Sale to Alcon - Stock Titan
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims - MarketScreener
STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis - Business Wire
59% premium to 90-day VWAP: STAAR Surgical backs $28 Alcon merger and urges stockholders to vote - Stock Titan
Major STAAR Surgical Investors Push Back On Alcon Acquisition - Finimize
5.05%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):